Image Source: DTNEXT

Agencies:

China approves first Nasal spray COVID-19 vaccine for trials

Beijing
September 11, 2020

China has approved for trials its first nasal spray vaccine to combat the Novel Coronavirus that has claimed over 9,04,000 lives and infected more than 27 million people globally, official media here reported on Thursday.

China's only nasal spray vaccine against the Coronavirus is expected to start phase I clinical trials in November and it is recruiting 100 volunteers.
It is the only vaccine of its type approved by China's National Medical Products Administration, the state run Global Times reported.

The vaccine is a collaborative mission between Hong Kong and the Chinese mainland that involves researchers from the University of Hong Kong, Xiamen University and Beijing Wantai Biological Pharmacy.